Company / PP&E (Net)
OMEROS CORP PP&E (Net) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$2.7M
FY2024
5-year range
$1.5M / $2.7M
FY2020-FY2024
Trend
+37.3%
vs FY2023
Sector context
#125 of 193
Health Care
What the data says
At $3M, OMEROS CORP's pp&e (net) ranks #125 of 193 in the Health Care sector. Improved from $1M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2024 with a 5-year CAGR of -6.9%.
Improved from $1M to $3M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +15.7%
- 5-Year CAGR
- -6.9%
- 10-Year CAGR
- -
Sector benchmark
#125 of 193 in Health CareTop 65% of 193This company $2.7M Sector average $777.6M
▼
-99.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -6.9%, indicating a declining trend.
- In FY2024, pp&e (net) increased 37.3% year-over-year.
- Ranks #125 out of 193 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.7M | +37.3% |
| FY2023 | $1.9M | +30.7% |
| FY2022 | $1.5M | -13.8% |
| FY2021 | $1.7M | - |
| FY2020 | - | - |
| FY2019 | $3.8M | -0.4% |
| FY2018 | $3.8M | +81.3% |
| FY2017 | $2.1M | +79.6% |
| FY2016 | $1.2M | +24.2% |
| FY2015 | $951.0K | +21.6% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026